Literature DB >> 9835538

Examination of methicillin-resistant and methicillin-susceptible Staphylococcus aureus mutants with low-level fluoroquinolone resistance.

M C Sulavik1, N L Barg.   

Abstract

For Staphylococcus aureus, stepwise mutations result in high-level quinolone resistance. Methicillin-resistant and -susceptible quinolone-resistant, first-step mutants generated in vitro were obtained and found to be no different than those recovered from murine abscesses. Approximately 10% of all first-step mutants were resistant to ethidium bromide, and selected strains had mutations that mapped to flqB. NorA-mediated resistance among first-step mutants may be more prevalent than previously reported.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9835538      PMCID: PMC106046     

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  23 in total

1.  Detection of gyrA gene mutations associated with ciprofloxacin resistance in methicillin-resistant Staphylococcus aureus: analysis by polymerase chain reaction and automated direct DNA sequencing.

Authors:  J J Goswitz; K E Willard; C E Fasching; L R Peterson
Journal:  Antimicrob Agents Chemother       Date:  1992-05       Impact factor: 5.191

2.  Activity of new quinolones against ciprofloxacin-resistant staphylococci.

Authors:  G J Forstall; C C Knapp; J A Washington
Journal:  Antimicrob Agents Chemother       Date:  1991-08       Impact factor: 5.191

3.  Emerging resistance to fluoroquinolones in staphylococci: an alert.

Authors:  M Trucksis; D C Hooper; J S Wolfson
Journal:  Ann Intern Med       Date:  1991-03-01       Impact factor: 25.391

4.  Confirmation of protoplast fusion-derived linkages in Staphylococcus aureus by transformation with protoplast DNA.

Authors:  M L Stahl; P A Pattee
Journal:  J Bacteriol       Date:  1983-04       Impact factor: 3.490

5.  DNA gyrase gyrA mutations in ciprofloxacin-resistant strains of Staphylococcus aureus: close similarity with quinolone resistance mutations in Escherichia coli.

Authors:  S Sreedharan; M Oram; B Jensen; L R Peterson; L M Fisher
Journal:  J Bacteriol       Date:  1990-12       Impact factor: 3.490

6.  Murine model of cutaneous infection with gram-positive cocci.

Authors:  C Bunce; L Wheeler; G Reed; J Musser; N Barg
Journal:  Infect Immun       Date:  1992-07       Impact factor: 3.441

7.  Mutations in topoisomerase IV and DNA gyrase of Staphylococcus aureus: novel pleiotropic effects on quinolone and coumarin activity.

Authors:  B Fournier; D C Hooper
Journal:  Antimicrob Agents Chemother       Date:  1998-01       Impact factor: 5.191

8.  A novel locus conferring fluoroquinolone resistance in Staphylococcus aureus.

Authors:  M Trucksis; J S Wolfson; D C Hooper
Journal:  J Bacteriol       Date:  1991-09       Impact factor: 3.490

9.  In vitro studies with five quinolones: evidence for changes in relative potency as quinolone resistance rises.

Authors:  K S Thomson; C C Sanders; M E Hayden
Journal:  Antimicrob Agents Chemother       Date:  1991-11       Impact factor: 5.191

10.  Differing activities of quinolones against ciprofloxacin-susceptible and ciprofloxacin-resistant, methicillin-resistant Staphylococcus aureus.

Authors:  P A Maple; J M Hamilton-Miller; W Brumfitt
Journal:  Antimicrob Agents Chemother       Date:  1991-02       Impact factor: 5.191

View more
  6 in total

1.  Multiple novel inhibitors of the NorA multidrug transporter of Staphylococcus aureus.

Authors:  P N Markham; E Westhaus; K Klyachko; M E Johnson; A A Neyfakh
Journal:  Antimicrob Agents Chemother       Date:  1999-10       Impact factor: 5.191

2.  Phenotypic resistance of Staphylococcus aureus, selected Enterobacteriaceae, and Pseudomonas aeruginosa after single and multiple in vitro exposures to ciprofloxacin, levofloxacin, and trovafloxacin.

Authors:  D N Gilbert; S J Kohlhepp; K A Slama; G Grunkemeier; G Lewis; R J Dworkin; S E Slaughter; J E Leggett
Journal:  Antimicrob Agents Chemother       Date:  2001-03       Impact factor: 5.191

3.  The Antimicrobial Activity of Ciprofloxacin-Loaded Niosomes against Ciprofloxacin-Resistant and Biofilm-Forming Staphylococcus aureus.

Authors:  Mona T Kashef; Nehal M Saleh; Nouran H Assar; Mohammed A Ramadan
Journal:  Infect Drug Resist       Date:  2020-06-08       Impact factor: 4.003

4.  Multidrug Efflux Pumps in Staphylococcus aureus: an Update.

Authors:  Sofia Santos Costa; Miguel Viveiros; Leonard Amaral; Isabel Couto
Journal:  Open Microbiol J       Date:  2013-03-22

5.  Resistance to Antimicrobials Mediated by Efflux Pumps in Staphylococcus aureus.

Authors:  Sofia S Costa; Elisabete Junqueira; Cláudia Palma; Miguel Viveiros; José Melo-Cristino; Leonard Amaral; Isabel Couto
Journal:  Antibiotics (Basel)       Date:  2013-03-13

6.  Impact of efflux in the development of multidrug resistance phenotypes in Staphylococcus aureus.

Authors:  Sofia Santos Costa; Miguel Viveiros; Adriana E Rosato; José Melo-Cristino; Isabel Couto
Journal:  BMC Microbiol       Date:  2015-10-24       Impact factor: 3.605

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.